Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors
AXL特异性抗体药物偶联物Enapotamab Vedotin治疗晚期实体瘤患者的I/II期研究
期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-25-0359
Rohrberg, Kristoffer Staal; Lopez, Juanita S; Milhem, Mohammed M; Blank, Christian U; Reijers, Irene; Thistlethwaite, Fiona; Plummer, Ruth; Piha-Paul, Sarina A; Jänne, Pasi A; Shum, Elaine; Shaw, Heather M; Debruyne, Philip R; Lao, Cristopher; Baurain, Jean-Francois; Choe, Jennifer H; Gort, Eelke; Zhao, Yujie; Jerusalem, Guy; Schöffski, Patrick; Chen, Andrew William; Cohen, Eric A; Mankowski, Walter C; Roshkovan, Leonid; Katz, Sharyn I; Kontos, Despina; Brady, Lauren K; Qutaish, Mohammed; Castro, Patricia Garrido; Pencheva, Nora; Bajaj, Gaurav; Fu, Yali; Windfeld, Kristian; Reiter, Panagiota; Jure-Kunkel, Maria; Higgs, Brandon W; Amiri, Katayoun I; Ahmadi, Tahamtan; Forssmann, Ulf; Ramalingam, Suresh S; Vergote, Ignace
